Comparative quantitative analysis of SARS- CoV-2 Spike neutralizing antibody titers following two anti COVID-19 vaccines in India

In COVID 19 Pandemic,first line of defence is effective vaccination program.Because of multiple platforms available for vaccine production we tested relative immunogenicity of two vaccines available in India, Covaxin® and Covishield® We performed quantitative analysis of neutralizing antibodies to SARS Cov2 spike (receptor binding domain) protein, from sera of 53 subjects who completed vaccines schedules.There was significantly higher immunogenic response with Covishield® as compared to Covaxin® and are independent of age. Studies on a large scale with long term follow up are needed to further advance the knowledge in this domain.